Alpha-Ketoglutarate Encyclopedia — Scientific Background

What Is Alpha-Ketoglutarate?

Alpha-ketoglutarate (AKG), also known as 2-oxoglutarate (2-OG) or 2-oxopentanedioic acid, is a dicarboxylic acid with the molecular formula C₅H₆O₅ and a molecular weight of 146.10 g/mol. It is a key intermediate in the Krebs cycle (citric acid cycle, TCA cycle), the central metabolic pathway for cellular energy production. AKG is also a nitrogen transporter and a precursor of amino acid biosynthesis, playing multiple essential roles in cellular metabolism.

The Krebs Cycle Connection

AKG is a central intermediate in the Krebs cycle, positioned at the intersection of multiple metabolic pathways. In the cycle, isocitrate is oxidized and decarboxylated to form AKG, which is then further oxidized to succinyl-CoA, generating NADH that feeds into the electron transport chain for ATP production. AKG also serves as a nitrogen shuttle, collecting excess nitrogen from amino acid metabolism and facilitating its elimination.

Mechanisms of Action

Epigenetic Regulation

AKG serves as an essential cofactor for a large family of dioxygenases—including TET enzymes that demethylate DNA and JmjC-domain-containing histone demethylases. These enzymes regulate DNA and histone methylation, thereby influencing gene expression. Through these epigenetic mechanisms, AKG plays a critical role in cellular differentiation, development, and aging. In mice, AKG supplementation has been shown to ameliorate age-related diseases such as osteoporosis via regulating histone methylations.

Cellular Energy Metabolism

As a key Krebs cycle intermediate, AKG directly supports mitochondrial ATP production. Studies on AKG in muscle health suggest that it supports muscle protein synthesis and mitochondrial activity, with compelling preclinical research on AKG as an anti-aging molecule that supports muscle, burning fat, and boosting mitochondrial activity.

Anti-Aging and Longevity

The anti-aging effects of AKG have been validated across multiple model organisms. In mice, dietary AKG supplementation extended both lifespan and healthspan, associated with reduced systemic inflammation and increased IL-10 levels. A clinical study using 1 g/day Ca-AKG with vitamins A and D for an average of 7 months demonstrated an average reduction in biological age of approximately 8 years in healthy individuals aged 40–65. Further studies suggest that AKG could ameliorate age-related diseases or function declines, including osteoporosis.

Metabolic Health Support

Exogenous supplementation of AKG improves obesity, blood glucose levels, and cardiovascular disease risks associated with metabolic syndrome. AKG regulates common pathological mechanisms of metabolic syndrome, including inflammation, oxidative stress, and metabolic dysfunction.

Immune Regulation

AKG plays physiological functions in immune regulation, oxidative stress, and anti-aging. It modulates immune cell function and contributes to the maintenance of immune homeostasis.

Neurological and Cognitive Function

Recent research has identified AKG as a circulatory exercise factor that promotes learning and memory recall. AKG acts as a prophylactic and antidepressant to effectively counteract social avoidance behaviors by modulating BDNF levels in the hippocampus and nucleus accumbens. AKG also plays an important role in preserving neurological function.

Sources and Production

AKG is produced in the human body as a natural component of the Krebs cycle. It is also naturally present in various foods, though in relatively small quantities. For commercial supplement production, AKG is produced through two primary methods:

• Microbial Fermentation — Engineered strains of Corynebacterium glutamicum and other microbial hosts have been developed for sustainable AKG production from renewable feedstocks such as molasses, with high titers of up to 195 g/L achieved.

• Chemical Synthesis — Industrial-scale production of AKG is traditionally achieved by chemical synthesis using several different methods.

The calcium salt form (Ca-AKG) is commonly used in supplements to enhance stability and bioavailability compared to free AKG.

The Bioavailability Challenge

Despite its central role in cellular metabolism, native AKG presents significant formulation challenges. AKG is a highly polar, water-soluble molecule that is rapidly absorbed and metabolized. Following oral administration, AKG is primarily taken up by the liver and rapidly converted to other metabolites, limiting its systemic availability and distribution to peripheral tissues.

liposomal encapsulation addresses these limitations through a biomimetic phospholipid bilayer that protects AKG during digestive transit, prevents premature metabolism, and facilitates direct delivery to mitochondria. Conventional pills and powders show limited AKG absorption, while the liposomal structure creates a protective layer around nutrients, keeping them away from gastric acid and maintaining optimal bioavailability.

Liposomal AKG

Liposomal encapsulation of AKG provides a fundamentally different delivery mechanism from conventional forms. The phospholipid bilayer surrounds the AKG molecule, forming a protective shell that enhances absorption and facilitates direct delivery to target tissues. This delivery system:

• Protects AKG from gastric acid degradation and premature metabolism

• Enhances intestinal absorption through lipid-mediated pathways

• Facilitates direct delivery to mitochondria, the primary site of AKG's metabolic activity

• Provides sustained release for prolonged metabolic support

Liposomal AKG is supplied as a sunflower phospholipid liposomal powder, typically as white to off-white fine powder. Quality control commonly focuses on active content, phospholipid carrier consistency, appearance, moisture, particle characteristics, microbial limits, heavy metals, and stability indicators.

Clinical Evidence

Biological Age Reduction

A clinical study by Demidenko et al. (2021) evaluated Ca-AKG (1 g/day) with vitamins A and D in 42 healthy individuals aged 40–65 years for an average of 7 months. The study demonstrated an average reduction in biological age of approximately 8 years as measured by DNA methylation. The ABLE trial (ongoing) is a randomized controlled trial evaluating sustained-release Ca-AKG at 1 g/day for 6 months in 120 healthy individuals aged 40–60 years with higher biological than chronological age, with the primary outcome being the decrease in DNA methylation age.

Metabolic Syndrome

Exogenous supplementation of AKG improves obesity, blood glucose levels, and cardiovascular disease risks associated with metabolic syndrome. AKG regulates the common pathological mechanisms of metabolic syndrome, including inflammation and oxidative stress.

Bone and Muscle Health

In postmenopausal women with osteopenia, a clinical trial (Filip et al., 2007) evaluated Ca-AKG at 6 g/day for 6 months and reported a trend toward improvement in bone mineral density compared to calcium alone. AKG has been shown to preserve skeletal muscle, with preclinical research indicating benefits for muscle protein turnover and regeneration.

Safety Profile

Several clinical trials using Ca-AKG in hemodialysis patients found it to be safe at doses up to 4.5 g/day, with increases in plasma arginine and decreases in plasma urea levels. In postmenopausal women, 6 g/day of Ca-AKG was used safely over 6 months.

Safety and Regulatory

Alpha-ketoglutarate and its calcium salt are generally well tolerated at commonly used doses. Clinical trials have used Ca-AKG at doses up to 6 g/day in postmenopausal women and up to 4.5 g/day in hemodialysis patients without serious adverse effects. The recommended dose of 1 g/day Ca-AKG for anti-aging applications has been used safely in clinical studies for up to 10 months. High doses may cause gastrointestinal discomfort in some individuals. Liposomal encapsulation helps reduce these side effects through sustained release and improved absorption. AKG is widely commercialized as a dietary supplement ingredient and is increasingly used in longevity and anti-aging formulations. Testing protocols must adhere to international standards including USP, European Pharmacopoeia, and FAO/WHO Codex Alimentarius. Formulators should verify local regulatory requirements prior to market entry.

This product is intended for research, nutraceutical, and functional food applications. Not intended to diagnose, treat, cure, or prevent any disease.

89$/KG

79$/KG